CJM061 is a WEE1 kinase inhibitor with a target IC 50 of 2.8 nM. CJM061 acts as a sensitizer and exhibits synergistic effects with Cisplatin ( HY-17394 ) in medulloblastoma cells. CJM061 can be used for the research of medulloblastoma.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > CNS Neoplasm | Products > Disease Areas > Glioma | Products > Disease Areas > Medulloblastoma | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Wee1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.